Matches in Wikidata for { <http://www.wikidata.org/entity/Q65387449> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q65387449 description "clinical trial" @default.
- Q65387449 description "ensayu clínicu" @default.
- Q65387449 description "klinisch onderzoek" @default.
- Q65387449 description "клінічне випробування" @default.
- Q65387449 description "կլինիկական փորձարկում" @default.
- Q65387449 name "Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin" @default.
- Q65387449 name "Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin" @default.
- Q65387449 type Item @default.
- Q65387449 label "Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin" @default.
- Q65387449 label "Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin" @default.
- Q65387449 prefLabel "Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin" @default.
- Q65387449 prefLabel "Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin" @default.
- Q65387449 P1050 Q65387449-1EAF4CBE-B03E-47C2-8E7F-A107E4D08A5C @default.
- Q65387449 P1132 Q65387449-2DDD0140-2352-4A91-BE56-3147DE6911CE @default.
- Q65387449 P1476 Q65387449-A12E4229-9644-4A82-BEF5-99C102C44FAB @default.
- Q65387449 P17 Q65387449-26441C28-C419-4FC6-9755-BE404D6F5236 @default.
- Q65387449 P17 Q65387449-30005CE9-DB84-4733-A6B0-127C488630A4 @default.
- Q65387449 P17 Q65387449-43BD65E2-4FB1-4F00-AFEA-63E38FF896E1 @default.
- Q65387449 P17 Q65387449-7F3AA894-5380-4831-8CCB-664A0230FB07 @default.
- Q65387449 P2899 Q65387449-59E54227-6ACF-4684-A8FC-D5004E5879A5 @default.
- Q65387449 P3098 Q65387449-1634F768-FA14-4E03-B60D-58EC47DD5B4A @default.
- Q65387449 P31 Q65387449-C5ACBD1F-DBD1-44F6-A564-C020FD0E6A18 @default.
- Q65387449 P4135 Q65387449-2146DDCB-9B8E-42FF-B1E3-B0FD9652C118 @default.
- Q65387449 P580 Q65387449-4D17AE9C-88CA-43E7-86A0-A38250BBC65F @default.
- Q65387449 P582 Q65387449-1C22C219-05D7-48E5-9CF8-269D29F2AD48 @default.
- Q65387449 P6099 Q65387449-77A3CF89-F028-41A3-99A2-FFE48D4FFEF1 @default.
- Q65387449 P6099 Q65387449-DA5E581C-DB08-4D22-96D1-E7A338D65434 @default.
- Q65387449 P6153 Q65387449-3790921B-FDFF-4238-9B9C-2C4C16ACBF2A @default.
- Q65387449 P6153 Q65387449-74653B73-4D34-4A46-83C6-ADBBFC189809 @default.
- Q65387449 P6153 Q65387449-F7B0A5B4-ACE2-4A9F-AFB5-7A17FE5807C3 @default.
- Q65387449 P6153 Q65387449-FED56D9C-5A06-4CE8-B711-71E5A20131C7 @default.
- Q65387449 P6153 Q65387449-FF4D7C81-3373-42ED-83B8-0513C77D7AA4 @default.
- Q65387449 P8363 Q65387449-560909E2-921D-422D-A669-08C716B5704D @default.
- Q65387449 P1050 Q12206 @default.
- Q65387449 P1132 "+396" @default.
- Q65387449 P1476 "Phase 2/3, Randomized, Double-blind, Placebo- and Active Comparator-controlled, Parallel, Multicenter Study to Determine Safety and Efficacy of Metaglidasen in Treatment of Type 2 Diabetes Suboptimally Controlled on Insulin" @default.
- Q65387449 P17 Q30 @default.
- Q65387449 P17 Q414 @default.
- Q65387449 P17 Q668 @default.
- Q65387449 P17 Q801 @default.
- Q65387449 P2899 "+18" @default.
- Q65387449 P3098 "NCT00353587" @default.
- Q65387449 P31 Q30612 @default.
- Q65387449 P4135 "+75" @default.
- Q65387449 P580 "2006-05-01T00:00:00Z" @default.
- Q65387449 P582 "2007-11-01T00:00:00Z" @default.
- Q65387449 P6099 Q42824440 @default.
- Q65387449 P6099 Q42824827 @default.
- Q65387449 P6153 Q16129695 @default.
- Q65387449 P6153 Q2067213 @default.
- Q65387449 P6153 Q2919386 @default.
- Q65387449 P6153 Q4748675 @default.
- Q65387449 P6153 Q7042086 @default.
- Q65387449 P8363 Q78089383 @default.